San Diego, CA, United States of America

Daniel Nasr-Church

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Daniel Nasr-Church - Pioneering Robotic Suturing Instruments

Introduction: Daniel Nasr-Church, an inventive mind based in San Diego, CA, has made significant strides in the field of medical technology through his innovative contributions. With a focus on enhancing surgical techniques, he is recognized for developing advanced solutions that improve patient care and surgical precision.

Latest Patents: Daniel holds a patent for his invention titled "Systems and methods for robotic endoluminal suturing instrument." This innovative suturing instrument features a flexible shaft with an articulatable bending section, and a needle end effector positioned at the distal end. Notably, the needle end effector incorporates a toggle-based rotation mechanism that allows for seamless switching of the needle's orientation, facilitating easy engagement and disengagement with a ferrule.

Career Highlights: Presently, Daniel is associated with Noah Medical Corporation, a company dedicated to advancing healthcare through innovative medical devices. His work focuses on the intersection of robotics and surgery, striving to refine techniques and enhance surgical outcomes.

Collaborations: Throughout his career, Daniel has collaborated with colleagues such as Neil Markwardt and Matthew Robert Penny. Together, they contribute to a culture of innovation and excellence within the medical technology sector, driving progress through teamwork and shared expertise.

Conclusion: Daniel Nasr-Church exemplifies the spirit of innovation in medical technology. His patented advancements represent a crucial step forward in robotic surgery, ultimately aiming to improve the quality of care for patients undergoing surgical procedures. As he continues to work at Noah Medical Corporation, his future contributions are eagerly anticipated by the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…